Quick UpdateI had a call today with Vahid, he was busy finishing off Q3 fins so it was kept fairly brief. (Monday Fins Will Be Released) I sent an email with a long list of questions. Here is a brief outline of the answers provided: Lots of updates coming next 30 days. Anvisa should be within the next week at which point and time there will be subsequent sales agreements announced with it. There will be a Euro update soon in regards to the samples delivered there for subsequent agreements. Asked about pronorth sales and he confirmed they have started and has heard there is very strong demand but didnt confirm numbers. In regards to HC, he confirmed with VSH that all questions have been answered and any additional data provided.As far as he knows there are no current road blocks and its in HCs hands. I asked about the Lab and he confirmed it was entirely purchased by VSH with no additional funds from VST so the breakdown remains the same. Confirmed they are working on an Antigen test although he didnt allude to further details. Spin-offs for Immersive and V2 just around the corner for Q4 and Q1 and they are discussing how to benefit VST investors through various possibilities with the best tax implications (spin off shares, etc). Telehealth/e-commerce update will be announced shortly.